[Problems of immunotoxicology].
D000276:Adjuvants, Immunologic / Q000627:therapeutic use / Q000633:toxicity; D000486:Allergy and Immunology / Q000639:trends*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use / Q000633:toxicity; D003577:Cytochrome P-450 Enzyme System / Q000096:biosynthesis; D004790:Enzyme Induction / Q000187:drug effects; D006706:Homeostasis / Q000187:drug effects; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007109:Immunity / Q000187:drug effects; D007120:Immunochemistry; D007166:Immunosuppressive Agents / Q000627:therapeutic use / Q000633:toxicity; D007369:Interferon Inducers / Q000627:therapeutic use / Q000633:toxicity; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000276:immunology; D010105:Oxygenases / Q000096:biosynthesis; D014116:Toxicology / Q000639:trends*
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D007369:Interferon Inducers; D003577:Cytochrome P-450 Enzyme System; D010105:Oxygenases
Problemy immunotoksikologii.